← Evidence map

ArticleNeuro-oncology practice2022

Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem.

Carmen BalanaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36134019